UM Ventures announces licensing agreement for breakthrough cancer drug delivery platform
Baltimore, MD, July 17, 2013 – UM Ventures has signed a licensing agreement with Rockville, Md.-based Rexahn Pharmaceuticals, Inc. for a newly-developed cancer drug delivery platform, Nano-Polymer-Drug Conjugate Systems (NPDCS). The technology helps target cancer-fighting drugs directly to tumors, minimizing …